Unibios Holdings (Greece) Performance
| BIOSK Stock | EUR 1.53 0.01 0.66% |
Unibios Holdings has a performance score of 3 on a scale of 0 to 100. The entity has a beta of -0.14, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Unibios Holdings are expected to decrease at a much lower rate. During the bear market, Unibios Holdings is likely to outperform the market. Unibios Holdings right now has a risk of 1.69%. Please validate Unibios Holdings treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Unibios Holdings will be following its existing price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Unibios Holdings SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Unibios Holdings is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 1.2 M | |
| Total Cashflows From Investing Activities | -45.7 K | |
| Free Cash Flow | 1 M |
Unibios |
Unibios Holdings Relative Risk vs. Return Landscape
If you would invest 148.00 in Unibios Holdings SA on November 3, 2024 and sell it today you would earn a total of 5.00 from holding Unibios Holdings SA or generate 3.38% return on investment over 90 days. Unibios Holdings SA is generating 0.0696% of daily returns and assumes 1.6935% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Unibios, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Unibios Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Unibios Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Unibios Holdings SA, and traders can use it to determine the average amount a Unibios Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0411
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BIOSK | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.69 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Unibios Holdings is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unibios Holdings by adding it to a well-diversified portfolio.
Unibios Holdings Fundamentals Growth
Unibios Stock prices reflect investors' perceptions of the future prospects and financial health of Unibios Holdings, and Unibios Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Unibios Stock performance.
| Return On Equity | 0.0246 | |||
| Return On Asset | 0.0181 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 16.01 M | |||
| Shares Outstanding | 15.51 M | |||
| Price To Earning | (0.81) X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 1.08 X | |||
| Revenue | 8.48 M | |||
| EBITDA | 1.29 M | |||
| Cash And Equivalents | 65.16 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 1.47 M | |||
| Debt To Equity | 106.40 % | |||
| Book Value Per Share | 0.82 X | |||
| Cash Flow From Operations | 1.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 23.62 M | |||
| Retained Earnings | (12 M) | |||
| Current Asset | 7 M | |||
| Current Liabilities | 7 M | |||
About Unibios Holdings Performance
By analyzing Unibios Holdings' fundamental ratios, stakeholders can gain valuable insights into Unibios Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Unibios Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Unibios Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe. Unibios Holdings S.A. was founded in 1940 and is based in Ano Liosia, Greece. UNIBIOS HOLDING is traded on Athens Stock Exchange in Greece.Things to note about Unibios Holdings performance evaluation
Checking the ongoing alerts about Unibios Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Unibios Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Unibios Holdings may become a speculative penny stock | |
| Unibios Holdings has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Unibios Holdings SA has accumulated 1.47 M in total debt with debt to equity ratio (D/E) of 106.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Unibios Holdings has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Unibios Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Unibios Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Unibios Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Unibios to invest in growth at high rates of return. When we think about Unibios Holdings' use of debt, we should always consider it together with cash and equity. | |
| About 39.0% of Unibios Holdings shares are held by company insiders |
- Analyzing Unibios Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Unibios Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Unibios Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Unibios Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Unibios Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Unibios Holdings' stock. These opinions can provide insight into Unibios Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Unibios Stock analysis
When running Unibios Holdings' price analysis, check to measure Unibios Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unibios Holdings is operating at the current time. Most of Unibios Holdings' value examination focuses on studying past and present price action to predict the probability of Unibios Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unibios Holdings' price. Additionally, you may evaluate how the addition of Unibios Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |